MediWound Ltd. (MDWD)
19.51
+0.14
(+0.72%)
USD |
NASDAQ |
Jan 08, 12:38
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 250.15M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 12.78% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 10.12 |
| Price to Book Value | 4.987 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.186 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 84.69% |
Profile
| MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product NexoBrid, is an orphan biologic for eschar removal in severe burns. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel. |
| URL | http://www.mediwound.com |
| Investor Relations URL | http://ir.mediwound.com/ |
| HQ State/Province | HaMerkaz |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Mar. 18, 2026 (est.) |
| Last Earnings Release | Nov. 20, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product NexoBrid, is an orphan biologic for eschar removal in severe burns. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel. |
| URL | http://www.mediwound.com |
| Investor Relations URL | http://ir.mediwound.com/ |
| HQ State/Province | HaMerkaz |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Mar. 18, 2026 (est.) |
| Last Earnings Release | Nov. 20, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |